Published in Biol Neonate on January 01, 1982
Simultaneous monitoring of gastric and oesophageal pH reveals limitations of conventional oesophageal pH monitoring in milk fed infants. Arch Dis Child (2001) 1.87
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46
Effects of gastrointestinal hormones on the growth of human intestinal epithelial cells in vitro. Gut (1989) 1.40
Gastrointestinal blood flow velocity after the first feed. Arch Dis Child (1991) 1.11
Prediction of early tolerance to enteral feeding in preterm infants by measurement of superior mesenteric artery blood flow velocity. Arch Dis Child Fetal Neonatal Ed (2001) 1.04
Feeding issues in preterm infants. Arch Dis Child Fetal Neonatal Ed (2000) 0.91
Nutrition in the 21st century: what is going wrong. Arch Dis Child (2004) 0.82
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97
Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet (2001) 4.94
Multicentre trial on feeding low birthweight infants: effects of diet on early growth. Arch Dis Child (1984) 4.62
Avoidable factors contributing to death of children with head injury. BMJ (1990) 4.33
Creamatocrit: simple clinical technique for estimating fat concentration and energy value of human milk. Br Med J (1978) 4.27
Duration of breast feeding and arterial distensibility in early adult life: population based study. BMJ (2001) 4.18
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62
A glucagonoma syndrome. Lancet (1974) 3.56
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Causes of fatal childhood accidents involving head injury in northern region, 1979-86. BMJ (1990) 3.29
Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (1973) 3.22
Observations on central and peripheral temperatures in the understanding and management of shock. Br J Surg (1969) 3.11
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (1976) 3.08
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
What is a normal rate of weight gain in infancy? Acta Paediatr (1994) 2.95
A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet (2000) 2.87
Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (2005) 2.80
Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut (1971) 2.75
Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics (2000) 2.73
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Neuron-specific enolase is produced by neuroendocrine tumours. Lancet (1981) 2.63
Measuring exposure to injury risk in schoolchildren aged 11-14. BMJ (1994) 2.52
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Measurement of fasting and postprandial plasma VIP in man. Gut (1978) 2.48
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Calculation difficulties in children of very low birthweight: a neural correlate. Brain (2001) 2.48
Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med (1996) 2.40
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Comparison of the use of Tanner and Whitehouse, NCHS, and Cambridge standards in infancy. Arch Dis Child (1993) 2.30
Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27
Gut-hormone profile in coeliac disease. Lancet (1978) 2.25
Unethical age assessment. Br Dent J (2009) 2.25
Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet (1989) 2.25
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24
Mother's choice to provide breast milk and developmental outcome. Arch Dis Child (1988) 2.21
Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20
Neural dysfunction during hypoglycaemia. Arch Dis Child (1988) 2.19
ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology (2001) 2.18
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Gut hormones and appetite control. Gastroenterology (2007) 2.16
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Iron fortified follow on formula from 9 to 18 months improves iron status but not development or growth: a randomised trial. Arch Dis Child (1999) 2.06
Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04
The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J Physiol (1973) 2.01
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest (2001) 2.01
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg (2006) 1.91
Annual incidence of unintentional injury among 54,000 children. Inj Prev (1996) 1.91
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes (1999) 1.90
Pattern of milk flow in breast-fed infants. Lancet (1979) 1.89
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci (1984) 1.88
Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat. J Physiol (1982) 1.84
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol (1990) 1.80
Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet (1987) 1.78
Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75
Head circumference as an index of brain weight in the fetus and newborn. Early Hum Dev (1977) 1.74
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 1.74
The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon. Br J Surg (1974) 1.73
Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child (1992) 1.73
Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72
Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab (1996) 1.72
Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med (1997) 1.71
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology (1980) 1.70
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Hippocampal volume and everyday memory in children of very low birth weight. Pediatr Res (2000) 1.69
Metabolic bone disease in preterm infants. Arch Dis Child (1985) 1.69
An enteroglucagon tumour. Gut (1972) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci (1979) 1.67
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
A radioimmunoassay for neurotensin in human plasma. J Endocrinol (1979) 1.66
Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology (1999) 1.65
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Organ-selective growth in the offspring of protein-restricted mothers. Br J Nutr (1996) 1.65
Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab (2002) 1.65
Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat. J Physiol (1980) 1.62
Changing trends in the management of phaeochromocytoma. Br J Surg (1998) 1.62
Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60
Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation (2001) 1.60
Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia (1990) 1.58
The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf. J Physiol (1974) 1.58